Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nexans SA | NEX | Jan 10, 2025 | 92.10 | -9.26 |
Nexity SA | NXI | Jan 10, 2025 | 12.43 | -3.57 |
Next 150 Index | N150 | Jan 10, 2025 | 3 282.33 | -0.83 |
Nextedia | ALNXT | Jan 10, 2025 | 0.45 | -2.17 |
NFL Biosciences S.A. | ALNFL | Jan 10, 2025 | 1.87 | +1.63 |
Nicolas Miguet and Associes S.A | MLNMA | Jan 10, 2025 | 0.06 | 0.00 |
Nicox SA | ALCOX | Jan 10, 2025 | 0.32 | -1.54 |
Nokia | NOKIA | Jan 10, 2025 | 4.40 | -0.09 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NBA | Jan 10, 2025 | 5.80 | -1.69 |
Novacyt | ALNOV | Jan 10, 2025 | 0.72 | -1.50 |
Novatech Industries | MLNOV | Jan 10, 2025 | 10.50 | 0.00 |
NR 21 | NR21 | Jan 10, 2025 | 34.40 | 0.00 |
NRJ Group | NRG | Jan 10, 2025 | 6.84 | -2.29 |
NSC Groupe | ALNSC | Jan 10, 2025 | 62.00 | 0.00 |
NSE SA | ALNSE | Jan 10, 2025 | 29.10 | +0.34 |
Obiz | ALBIZ | Jan 10, 2025 | 4.90 | +0.41 |
Odyssee Technologies S.A. | ALODY | Jan 10, 2025 | 15.10 | 0.00 |
Oeneo | SBT | Jan 10, 2025 | 9.60 | -1.03 |
Omer-Decugis & Cie | ALODC | Jan 10, 2025 | 4.20 | 0.00 |
Oncodesign Precision Medicine S.A | ALOPM | Jan 10, 2025 | 0.68 | +3.03 |
One Experience | ALEXP | Jan 10, 2025 | 0.40 | 0.00 |
Onlineformapro | MLONL | Jan 10, 2025 | 1.40 | 0.00 |
OPmobility | OPM | Jan 10, 2025 | 10.24 | -0.78 |
Orange. | ORA | Jan 10, 2025 | 9.71 | +0.68 |
Ordissimo | ALORD | Jan 10, 2025 | 0.71 | +5.67 |
Orege | OREGE | Jan 10, 2025 | 0.43 | +1.17 |
OSE Immunotherapeutics | OSE | Jan 10, 2025 | 6.75 | -1.46 |
Osmosun S.A | ALWTR | Jan 10, 2025 | 1.83 | -4.19 |
OVH GROUPE (PROM.)EO 1 | OVH | Jan 10, 2025 | 7.73 | -7.15 |
Pacte Novation | MLPAC | Jan 10, 2025 | 9.80 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.